Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT)

Historical Holders from Q1 2014 to Q3 2025

Symbol: SRPT on Nasdaq
Type / Class: Equity / Common Stock, $0.0001 par value per share
Shares outstanding: 105,632,895
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 86,806,840
Holdings value: $1,674,704,200
% of all portfolios: 0%
Number of holders: 309
Number of buys: 168
Number of sells: -209
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
VANGUARD GROUP INC	10.9%		$190,912,690		10,641,733		The Vanguard Group	29 Aug 2025
STATE STREET CORP	5.4%		$102,225,558		5,304,907		STATE STREET CORPORATION	30 Sep 2025
D. E. SHAW & CO, L.P.	1.9%	-64%	$38,675,372	-$58,829,132	2,007,025	-60.3%	D. E. Shaw & Co., L.P.	30 Sep 2025
Capital International Investors	0.5%	-97.8%	$9,523,733	-$152,120,639	524,146	-94.1%	Capital International Investors	30 Jun 2025

Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	86,806,840	$1,674,704,200	+$92,781,986	$114,132,357	$102,091,105	$19.27	309
2025 Q2	82,768,888	$1,414,059,003	-$616,173,124	$68,878,093	$93,318,012	$17.10	354
2025 Q1	85,664,154	$5,483,381,207	-$371,527,547	$62,904,672	$80,276,199	$63.82	419
2024 Q4	87,843,903	$10,682,091,570	+$115,071,840	$146,062,992	$172,177,637	$121.59	459
2024 Q3	86,796,388	$10,834,992,283	-$451,898,219	$174,183,882	$245,854,560	$124.89	451
2024 Q2	88,782,224	$14,026,709,174	+$922,747,140	$253,921,800	$550,487,400	$158.00	479
2024 Q1	83,236,471	$10,771,794,424	+$210,287,311	$140,786,310	$516,415,940	$129.46	408
2023 Q4	81,574,475	$7,866,654,991	-$295,015,527	$259,039,659	$482,921,440	$96.43	386
2023 Q3	83,265,476	$10,092,124,857	+$213,088,130	$371,115,030	$441,410,508	$121.22	390
2023 Q2	81,723,093	$9,359,752,457	+$62,411,602	$304,087,320	$203,236,860	$114.52	399
2023 Q1	81,211,200	$11,191,507,838	+$325,102,660	$358,606,262	$334,124,492	$137.83	422
2022 Q4	78,931,000	$10,227,280,074	+$92,872,677	$214,299,702	$214,273,522	$129.58	405
2022 Q3	78,254,620	$8,650,122,111	+$568,958,858	$143,307,100	$173,183,370	$110.54	364
2022 Q2	73,313,897	$5,496,320,989	+$35,960,887	$70,650,400	$83,698,800	$74.96	312
2022 Q1	73,015,967	$5,705,221,328	+$56,363,206	$67,560,800	$74,611,600	$78.12	314
2021 Q4	71,894,248	$6,474,592,585	+$536,221,296	$157,545,490	$202,414,570	$90.05	326
2021 Q3	65,753,485	$6,079,879,477	+$130,063,243	$103,318,000	$121,762,000	$92.48	297
2021 Q2	64,801,548	$5,037,256,042	-$83,636,915	$85,306,000	$79,744,280	$77.74	315
2021 Q1	66,263,834	$4,936,320,529	-$714,137,111	$124,574,000	$93,845,250	$74.53	346
2020 Q4	70,628,202	$12,036,993,873	-$160,139,710	$577,157,896	$551,498,000	$170.49	435
2020 Q3	72,104,327	$10,123,672,605	-$335,637,260	$343,178,000	$276,712,000	$140.43	393
2020 Q2	73,863,151	$11,844,121,308	+$150,679,056	$225,623,000	$259,019,000	$160.34	397
2020 Q1	73,412,115	$7,179,418,082	-$46,251,906	$190,742,000	$144,588,000	$97.82	346
2019 Q4	73,511,794	$9,484,309,752	+$56,244,489	$332,763,000	$479,713,000	$129.04	379
2019 Q3	73,245,840	$5,516,516,594	-$252,303,319	$214,894,000	$196,200,000	$75.32	329
2019 Q2	71,710,913	$10,889,813,246	+$292,081,135	$383,705,000	$419,947,000	$151.95	359
2019 Q1	71,059,216	$8,477,596,090	+$290,725,751	$244,793,000	$290,775,000	$119.19	359
2018 Q4	68,661,818	$7,492,575,765	+$726,945,004	$153,658,000	$232,369,000	$109.13	325
2018 Q3	61,212,693	$9,884,755,828	+$245,516,894	$282,933,000	$348,856,000	$161.51	336
2018 Q2	59,953,943	$7,924,528,334	+$548,877,233	$239,234,000	$246,754,000	$132.18	311
2018 Q1	56,761,587	$4,203,831,314	+$181,642,965	$99,808,000	$142,526,000	$74.09	265
2017 Q4	55,206,092	$3,072,290,058	+$54,898,638	$271,074,000	$237,514,000	$55.64	246
2017 Q3	53,730,465	$2,441,631,878	+$525,830,388	$223,375,000	$236,484,000	$45.36	229
2017 Q2	42,713,217	$1,439,533,207	+$80,813,352	$70,865,000	$89,424,000	$33.71	186
2017 Q1	40,738,464	$1,205,704,254	+$221,363,966	$49,726,000	$73,218,000	$29.60	177
2016 Q4	39,367,759	$1,079,914,087	-$175,937,880	$119,225,000	$168,588,000	$27.43	175
2016 Q3	42,406,897	$2,603,203,193	+$578,983,777	$532,515,000	$414,018,000	$61.41	183
2016 Q2	34,630,592	$660,414,393	-$14,436,681	$344,465,000	$178,041,000	$19.07	142
2016 Q1	35,134,647	$685,755,808	+$88,658,017	$59,236,000	$65,765,000	$19.52	129
2015 Q4	28,532,796	$1,100,883,608	+$34,445,813	$75,087,000	$147,730,000	$38.58	146
2015 Q3	27,764,899	$891,509,724	+$36,642,722	$33,928,000	$59,040,000	$32.11	145
2015 Q2	26,667,019	$811,458,439	+$87,268,791	$24,092,000	$57,167,000	$30.43	127
2015 Q1	24,203,223	$321,208,632	-$7,502,400	$5,928,000	$23,849,000	$13.28	111
2014 Q4	24,718,769	$357,295,111	-$43,901,247	$19,109,000	$45,877,000	$14.47	118
2014 Q3	25,967,938	$547,925,873	-$18,480,997	$29,711,000	$90,944,000	$21.10	121
2014 Q2	26,655,127	$794,069,375	+$1,202,234	$49,103,000	$36,201,000	$29.79	126
2014 Q1	26,596,410	$639,243,096	-$12,446,044	$62,446,000	$70,265,000	$24.03	114